等待开盘 02-20 09:30:00 美东时间
-0.220
-1.00%
今日重点评级关注:HC Wainwright & Co.:维持内克塔治疗"买入"评级,目标价从135美元升至165美元;BTIG:维持内克塔治疗"买入"评级,目标价从118美元升至151美元
02-11 11:02
Morgan Stanley analyst James Faucette maintains i3 Verticals (NASDAQ:IIIV) with a Equal-Weight and lowers the price target from $28 to $22.
02-10 23:09
今日重点评级关注:瑞杰金融:上调Lumexa Imaging Holdings评级至"强力买入",目标价23美元;BTIG:维持Transocean"买入"评级,目标价从6美元升至10美元
02-10 10:29
The earnings results for i3 Verticals (NASDAQ:IIIV) for Q1 were made public on ...
02-06 05:18
Companies Reporting Before The Bell • WEC Energy Group (NYSE:WEC) is estimated ...
02-05 19:11
今日重点评级关注:Benchmark:维持Charter Communications"买入"评级,目标价从425美元升至455美元;BTIG:维持LifeStance Health Gr"买入"评级,目标价从10美元升至11美元
02-03 09:06
DA Davidson analyst Peter Heckmann maintains i3 Verticals (NASDAQ:IIIV) with a Buy and maintains $35 price target.
02-03 04:37
i3 Verticals Inc. published an update to their financial calendar i3 Verticals Inc. will release its first quarter fiscal 2026 financial results on Thursday, February 5, 2026, after the Nasdaq market close. Results will be available in the "Investors" section of the Company's website on the "Events
01-23 00:00
Paul Christians, Chief Revenue Officer of i3 Verticals Inc., reported a disposal of common shares of i3 Verticals Inc. The full filing can be accessed through the link below. Disclaimer: This news bri...
2025-12-02 06:08
今日重点评级关注:Ascendiant Capital:维持Aclarion"买入"评级,目标价从22美元升至23美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从24美元升至26美元
2025-11-21 15:50